While this side effect tends to lessen over time, it can still cause discomfort and affect your quality of life
But have you thought about what all this might be doing to your nutrient levels
Liraglutide (Lirafit), a glucagon-like peptide-1 receptor agonist (GLP-1 RA) is the latest affordable offering from Glenmark, marking its entry into the injectable anti-diabetic market
It enhances the actions of insulin in the body by stimulating GIP receptors, allowing cells to control the amount of sugar present in the blood
Semaglutide has emerged as a major player in both weight loss and diabetes management
Authors relationships and activities TN has received consultancy fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Merck and Sanofi